Related Experiment Video
Updated: Jun 11, 2025

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Anterior pituitary hormone dysfunction among individuals with complete heart block requiring pacemaker
Bashir Ahmad Laway1, Arun Viswanath S1, Mohammad Salem Baba1
1Department of Endocrinology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu & Kashmir, India.
Insights
Complete heart block (CHB) patients may develop hypopituitarism, characterized by anterior pituitary hormone loss. This study found significant hormone deficiencies in CHB individuals at 12-month follow-up, highlighting potential risks.
Area of Science:
- Endocrinology
- Cardiology
- Neurology
Background:
- Neuronal hypoxia, linked to traumatic brain injury and cardiac arrhythmias, is associated with hypopituitarism.
- Individuals with complete heart block (CHB) may be susceptible to long-term anterior pituitary hormone dysfunction.
Purpose of the Study:
- To investigate anterior pituitary hormone functions in individuals following CHB.
- To assess the prevalence of hypopituitarism in CHB patients.
Main Methods:
- A prospective cohort study of 30 CHB patients undergoing pacemaker implantation.
- Hormone levels (FSH, LH, TSH, TT4, FT4, cortisol, IGF-1, testosterone, estradiol) were measured.
- Fixed-dose glucagon stimulation test (GST) assessed growth hormone (GH) and adrenocorticotrophic hormone (ACTH) axes.
Main Results:
- At 12-month follow-up, 56.7% had low IGF-1, with 23% diagnosed with growth hormone deficiency (GHD).
- 20% exhibited ACTH deficiency, and one patient had TSH deficiency.
- Overall, 30% of participants showed anterior pituitary hormone deficiencies.
Conclusions:
- This pilot study indicates a significant incidence of anterior pituitary hormone loss in CHB individuals at 12 months.
- Undiagnosed hypopituitarism in CHB patients may contribute to morbidity and mortality.
- Further research is warranted to explore the long-term consequences and management strategies.
Abstract:
Background & objectives Neuronal hypoxia associated with conditions like traumatic brain injury and cardiac tachyarrhythmia has been implicated in causing hypopituitarism. Individuals with complete heart block (CHB) may be predisposed to develop anterior pituitary hormone dysfunction in the long term. The objective of this study was to investigate anterior pituitary hormone functions in individuals after CHB. Methods This prospective cohort study included 30 individuals (21 men and 9 women) with CHB requiring pacemaker implantation, who were evaluated at admission and then at a mean follow up of 12.4 ± 2.2 months to look for development of any degree of hypopituitarism. In addition to the measurement of hormones like follicle-stimulating hormone (FSH), luteinising hormone (LH), thyroid stimulating hormone (TSH), total tetra iodothyronines (TT4), free tetraiodothyronines (FT4), cortisol, insulin-like growth factor-1 (IGF-1), testosterone and estradiol, a fixed-dose glucagon stimulation test (GST) was performed to assess growth hormone (GH) and adrenocorticotrophic hormone (ACTH) axis. Results The mean age of the participants was 64.9 ± 11.3 yr. At follow up evaluation, 17 (56.7%) had low serum IGF-1, and among them, seven (23%) had growth hormone deficiency (GHD) (peak GH <1.0 ng/ml after GST). Six participants (20%) had ACTH deficiency (peak cortisol <9 ug/dl after GST) and one had TSH deficiency. None had prolactin (PRL) or gonadotropin deficiency. Overall, hormone deficiencies were observed in nine patients (30%). Interpretation & conclusions This pilot study detected loss of anterior pituitary hormones in a significant number of individuals of CHB at 12 months follow up. Unrecognised hypopituitarism may have resulted in significant morbidity and mortality in these individuals.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Mechanism of Cardiac Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...

